Interestingly, we found that ICC patients with prior malignancy had better tumor-related profiles than those without prior cancer, namely, the former patients showed a lower proportion of positive AFP levels and vascular invasion, a lower AJCC stage, a smaller tumor size, and a lower stage of tumor grade. The gene discussed is AFP; the disease is cancer.